Study Warns: Aggressive Blood Pressure Lowering May Harm Kidney Patients
A recent study published in Neurology® has raised concerns about intensive blood pressure-lowering therapy in patients with impaired kidney function. Led by Kazunori Toyoda at the National Cerebral and Cardiovascular Center in Japan, the research suggests that such therapy may increase the risk of death or disability in these patients.
The study, which involved patients with intracerebral hemorrhage, found that those with decreased kidney function (eGFR < 60) had a significantly higher rate of death or disability (almost 50%) compared to those with normal kidney function (about 32%). This indicates that excessive blood pressure reduction for acute intracerebral hemorrhage can be risky for people with decreased kidney function.
The study, led by Mayumi Fukuda-Doi, was published in the scientific journal Neurology®. It highlights the need for further research to determine the appropriate target blood pressure range for intracerebral hemorrhage patients with kidney dysfunction. The authors emphasize that renal function should be considered when deciding the optimal blood pressure range for each patient.
The study underscores the importance of careful consideration of renal function when managing blood pressure in intracerebral hemorrhage patients. Further research is needed to establish the optimal blood pressure range for these patients, particularly those with kidney dysfunction.
